21st Century Access

October 28, 2025
Schuyler Ballroom
Even the most advanced 21st Century innovations cannot help patients if the 21st Century reimbursement paradigm prevents patients from accessing them. Join the conversation and discuss concrete steps policymakers can take to ensure patients benefit from cutting edge biotechnologies.
Moderator
Michele Oshman
Michele Oshman, Chief Patient Advocate and Head, Patient Advocacy Center of Excellence - Biotechnology Innovation Organization (BIO)
Speakers
Leah Howard
Leah Howard, President and CEO - National Psoriasis Foundation
Al Reba
Al Reba, Senior Vice President of Immunology & Cardiovascular Commercialization - Bristol Myers Squibb